Related Experiment Video

Updated: May 8, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Management of neonatal jaundice varies by practitioner type

Patrocinio C Mateo1, Kyong-Soon Lee, Matthew Barozzino

  • 1Covenant Health, Edmonton, Alta., Canada.

Canadian Family Physician Medecin De Famille Canadien
|August 16, 2013
PubMed

Insights

Pediatricians most closely follow national guidelines for neonatal hyperbilirubinemia management, while family physicians lag behind. Improved knowledge translation is needed to ensure consistent jaundice care for all newborns.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Public Health

Background:

  • Neonatal hyperbilirubinemia (jaundice) is a common condition requiring careful management.
  • National guidelines exist for the screening and management of neonatal jaundice.
  • Adherence to these guidelines may vary among different healthcare provider types.

Purpose of the Study:

  • To assess adherence to national neonatal hyperbilirubinemia guidelines among various medical practitioners in Ontario.
  • To identify differences in screening, follow-up, and management practices.

Main Methods:

  • An anonymized, cross-sectional survey was distributed to general practitioners, family physicians, pediatricians, and midwives in Ontario.
  • The survey assessed compliance with national guidelines for neonatal jaundice screening, postdischarge follow-up, and management.
  • Response rate was 17% (321/1890).

Main Results:

  • Only 41% of family physicians reported using national guidelines, compared to 75% of pediatricians and 69% of midwives (P < .001).
  • Screening before discharge varied: 42% of family physicians, 63% of pediatricians, and 22% of midwives.
  • Newborn follow-up within 72 hours was reported by 60% of family physicians, 89% of pediatricians, and 100% of midwives. Management of hyperbilirubinemia cases also showed significant differences.

Conclusions:

  • Significant variation exists in neonatal hyperbilirubinemia management practices among different practitioner types.
  • Pediatricians demonstrated the highest awareness and adherence to national guidelines.
  • Targeted knowledge translation efforts are crucial to improve guideline adherence, especially among family physicians.
Abstract

More Related Videos

Isolation of Neonatal Extrahepatic Cholangiocytes07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...